FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Chauncey

Research Profile

Procedures

Disorders

Concepts & Ideas

Phenomena

Recurrence

Chemicals & Drugs

Physiology

Graft Survival

Co-author Network

Publications

TOP 3
William I Bensinger; Thomas R Chauncey; L Holmberg; Marcello Rotta; B M Sandmaier; Rainer Storb; Barry Storer; P Becker; David Maloney
Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center.
Marco Mielcarek; Robert S Negrin; Rainer Storb; Barry Storer; Thomas R Chauncey; Mary E Flowers; Stephen J Forman; Yoshihiro Inamoto; Paul J Martin; Frederick R Appelbaum; William I Bensinger
Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.
Bart L Scott; Mohamed L Sorror; Rainer Storb; Frederick R Appelbaum; Veronika Buxhofer-Ausch; Thomas R Chauncey; Theodore A Gooley; Jonathan Grim; Michael L Linenberger; David Myerson; Jerald P Radich; Andrew R Rezvani; Brenda M Sandmaier; H Joachim Deeg
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Chauncey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: William I Bensinger; Thomas R Chauncey; L Holmberg; Marcello Rotta; B M Sandmaier; Rainer Storb; Barry Storer; P Becker; David Maloney
Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center.
Bone marrow transplantation 2012;47(10):1312-7.
2012: Marco Mielcarek; Robert S Negrin; Rainer Storb; Barry Storer; Thomas R Chauncey; Mary E Flowers; Stephen J Forman; Yoshihiro Inamoto; Paul J Martin; Frederick R Appelbaum; William I Bensinger
Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.
Blood 2012;119(11):2675-8.
2012: Bart L Scott; Mohamed L Sorror; Rainer Storb; Frederick R Appelbaum; Veronika Buxhofer-Ausch; Thomas R Chauncey; Theodore A Gooley; Jonathan Grim; Michael L Linenberger; David Myerson; Jerald P Radich; Andrew R Rezvani; Brenda M Sandmaier; H Joachim Deeg
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.
Blood 2012;119(11):2657-64.
2011: Mohamed L Sorror; Barry E Storer; Lars Vindeløv; Andrew Yeager; Edward Agura; Wolfgang Bethge; Karl G Blume; Benedetto Bruno; Thomas R Chauncey; Georg N Franke; George E Georges; Parameswaran Hari; Kai Hübel; Amelia Langston; Ginna G Laport; David G Maloney; Michael B Maris; Richard T Maziarz; Peter A McSweeney; Marco Mielcarek; Dietger Niederwieser; Finn Bo Petersen; Michael Allen Pulsipher; Firoozeh Sahebi; Brenda M Sandmaier; Rainer Storb
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
JAMA : the journal of the American Medical Association 2011;306(17):1874-83.
2011: Ron Ram; Brenda M Sandmaier; Rainer Storb; Barry Storer; Ann Woolfrey; Thoralf Lange; Amelia A Langston; Ginna G Laport; David G Maloney; Michael B Maris; Thomas R Chauncey; Mary E D Flowers; George E Georges
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Haematologica 2011;96(8):1113-20.
2010: Boglarka Gyurkocza; Rainer Storb; Barry E Storer; Thomas R Chauncey; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael Allen Pulsipher; Christopher N Bredeson; Richard T Maziarz; Benedetto Bruno; Finn B Petersen; Michael B Maris; Edward Agura; Andrew Yeager; Wolfgang A Bethge; Firoozeh Sahebi; Frederick R Appelbaum; David G Maloney; Brenda M Sandmaier
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2859-67.
2010: Hirohisa Nakamae; Barry E Storer; Rainer Storb; Jan Storek; Thomas R Chauncey; Michael Allen Pulsipher; Finn B Petersen; James C Wade; Michael B Maris; Benedetto Bruno; Jens Panse; Effie Petersdorf; Ann Woolfrey; David G Maloney; Brenda M Sandmaier
Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(3):384-94.
2010: Thomas R Chauncey; Holly Gundacker; Mazyar Shadman; Alan F List; Shaker R Dakhil; Harry P Erba; Marilyn L Slovak; I-Ming Chen; Cheryl L Willman; Kenneth J Kopecky; Frederick R Appelbaum
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.
British journal of haematology 2010;148(1):48-58.
2009: Terry Furlong; Paul Martin; Mary E D Flowers; F Carnevale-Schianca; R Yatscoff; Thomas R Chauncey; Frederick R Appelbaum; H Joachim Deeg; Kristine C Doney; Robert P Witherspoon; Barry Storer; Keith M Sullivan; Rainer Storb; Richard A Nash
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.
Bone marrow transplantation 2009;44(11):739-48.
2009: Frédéric Baron; Effie W Petersdorf; Ted Gooley; Brenda M Sandmaier; Mari Malkki; Thomas R Chauncey; David G Maloney; Rainer Storb
What is the role for donor natural killer cells after nonmyeloablative conditioning?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(5):580-8.
2009: Marcello Rotta; Barry E Storer; Firoozeh Sahebi; Judith A Shizuru; Benedetto Bruno; Thoralf Lange; Edward D Agura; Peter A McSweeney; Michael Allen Pulsipher; Parameswaran Hari; Richard T Maziarz; Thomas R Chauncey; Frederick R Appelbaum; Mohamed L Sorror; William I Bensinger; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 2009;113(14):3383-91.
2008: Andrew R Rezvani; Lalitha Norasetthada; Ted Gooley; Mohamed Sorror; Michelle E Bouvier; Firoozeh Sahebi; Edward Agura; Thomas R Chauncey; Richard T Maziarz; Michael Maris; Judith Shizuru; Benedetto Bruno; Christopher Bredeson; Thoralf Lange; Andrew Yeager; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
British journal of haematology 2008;143(3):395-403.
2008: Mohamed L Sorror; Barry E Storer; Brenda M Sandmaier; Michael B Maris; Judith A Shizuru; Richard T Maziarz; Edward Agura; Thomas R Chauncey; Michael Allen Pulsipher; Peter A McSweeney; James C Wade; Benedetto Bruno; Amelia A Langston; Jerald P Radich; Dietger Niederwieser; Karl G Blume; Rainer Storb; David G Maloney
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4912-20.
2008: Bart L Scott; J Y Park; H Joachim Deeg; Kieren Marr; Michael Boeckh; Thomas R Chauncey; Frederick R Appelbaum; Rainer Storb; Barry E Storer
Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):799-806.
2008: Mohamed Sorror; Barry Storer; Brenda M Sandmaier; David G Maloney; Thomas R Chauncey; Amelia Langston; Richard T Maziarz; Michael Allen Pulsipher; Peter A McSweeney; Rainer Storb
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
Cancer 2008;112(9):1992-2001.
2008: Ginna G Laport; Brenda M Sandmaier; Barry E Storer; Bart L Scott; Monic J Stuart; Thoralf Lange; Michael B Maris; Edward D Agura; Thomas R Chauncey; Ruby M Wong; Stephen J Forman; Finn B Petersen; James C Wade; Elliot M Epner; Benedetto Bruno; Wolfgang A Bethge; Peter T Curtin; David G Maloney; Karl G Blume; Rainer F Storb
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):246-55.
2008: Andrew R Rezvani; Barry Storer; Michael B Maris; Mohamed L Sorror; Edward Agura; Richard T Maziarz; James C Wade; Thomas R Chauncey; Stephen J Forman; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael Allen Pulsipher; Brenda M Sandmaier; Rainer Storb; David G Maloney
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):211-7.
2007: Christoph Kahl; Barry E Storer; Brenda M Sandmaier; Marco Mielcarek; Michael B Maris; Karl G Blume; Dietger Niederwieser; Thomas R Chauncey; Stephen J Forman; Edward Agura; Jose F Leis; Benedetto Bruno; Amelia A Langston; Michael Allen Pulsipher; Peter A McSweeney; James C Wade; Elliot M Epner; Finn Bo Petersen; Wolfgang A Bethge; David G Maloney; Rainer Storb
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2007;110(7):2744-8.
2007: Frédéric Baron; Brenda M Sandmaier; Barry E Storer; Michael B Maris; Amelia A Langston; Thoralf Lange; Effie W Petersdorf; Wolfgang A Bethge; Richard T Maziarz; Peter A McSweeney; Michael Allen Pulsipher; James C Wade; Thomas R Chauncey; Judith A Shizuru; Mohamed L Sorror; Ann Woolfrey; David G Maloney; Rainer Storb
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1041-8.
2007: George E Georges; Michael B Maris; David G Maloney; Brenda M Sandmaier; Mohamed L Sorror; Judith A Shizuru; Thoralf Lange; Edward D Agura; Benedetto Bruno; Peter A McSweeney; Michael Allen Pulsipher; Thomas R Chauncey; Marco Mielcarek; Barry E Storer; Rainer Storb
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):423-32.
2006: Frédéric Baron; Rainer Storb; Barry E Storer; Michael B Maris; Dietger Niederwieser; Judith A Shizuru; Thomas R Chauncey; Benedetto Bruno; Stephen J Forman; Peter A McSweeney; Richard T Maziarz; Michael Allen Pulsipher; Edward D Agura; James Wade; Mohamed L Sorror; David G Maloney; Brenda M Sandmaier
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4150-7.
2006: Michael B Maris; Brenda M Sandmaier; Barry E Storer; David G Maloney; Judith A Shizuru; Edward Agura; Constanze Kliem; Michael Allen Pulsipher; Richard T Maziarz; Peter A McSweeney; James Wade; Amelia A Langston; Thomas R Chauncey; Benedetto Bruno; Karl G Blume; Rainer Storb
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):454-65.
2006: Lauri Burroughs; Marco Mielcarek; Wendy Leisenring; Brenda M Sandmaier; David G Maloney; Frédéric Baron; Paul J Martin; Mary E D Flowers; Stephen J Forman; Thomas R Chauncey; Benedetto Bruno; Rainer Storb
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Transplantation 2006;81(6):818-25.
2006: Ute Hegenbart; Dietger Niederwieser; Brenda M Sandmaier; Michael B Maris; Judith A Shizuru; Hildegard Greinix; Catherine Cordonnier; Bernard Rio; Alois Gratwohl; Thoralf Lange; Haifa-Kathrin Al-Ali; Barry Storer; David Maloney; Peter McSweeney; Thomas R Chauncey; Edward Agura; Benedetto Bruno; Richard T Maziarz; Finn Petersen; Rainer Storb
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):444-53.
2006: Bart L Scott; Brenda M Sandmaier; Barry Storer; Michael B Maris; Mohamed L Sorror; David G Maloney; Thomas R Chauncey; Rainer Storb; H Joachim Deeg
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
Leukemia 2006;20(1):128-35.
2005: Christoph Kahl; Wendy Leisenring; H Joachim Deeg; Thomas R Chauncey; Mary E D Flowers; Paul J Martin; Jean E Sanders; Rainer Storb
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
British journal of haematology 2005;130(5):747-51.
2005: Mohamed L Sorror; Michael B Maris; Brenda M Sandmaier; Barry E Storer; Monic J Stuart; Ute Hegenbart; Edward Agura; Thomas R Chauncey; Jose Leis; Michael Allen Pulsipher; Peter McSweeney; Jerald P Radich; Christopher N Bredeson; Benedetto Bruno; Amelia A Langston; Michael R Loken; Haifa-Kathrin Al-Ali; Karl G Blume; Rainer Storb; David G Maloney
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3819-29.
2005: Fabio R Kerbauy; Rainer Storb; Ute Hegenbart; Ted Gooley; Judith A Shizuru; Haifa-Kathrin Al-Ali; Jerald P Radich; David G Maloney; Edward Agura; Benedetto Bruno; Elliot M Epner; Thomas R Chauncey; Karl G Blume; Dietger Niederwieser; Brenda M Sandmaier
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
Leukemia 2005;19(6):990-7.
2005: Marco Mielcarek; Lauri Burroughs; Wendy Leisenring; Razvan Diaconescu; Paul J Martin; Brenda M Sandmaier; David G Maloney; Michael B Maris; Thomas R Chauncey; Judith A Shizuru; Karl G Blume; Ute Hegenbart; Dietger Niederwieser; Stephen Forman; Benedetto Bruno; Ann Woolfrey; Rainer Storb
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
British journal of haematology 2005;129(3):381-91.
2005: Frédéric Baron; Michael B Maris; Barry E Storer; Brenda M Sandmaier; Jens P Panse; Thomas R Chauncey; Mohamed L Sorror; Marie-Térèse Little; David G Maloney; Rainer Storb; Shelly Heimfeld
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Leukemia 2005;19(5):822-8.
2005: Frédéric Baron; Michael B Maris; Barry E Storer; Brenda M Sandmaier; Monic J Stuart; Peter A McSweeney; Jerald P Radich; Michael Allen Pulsipher; Edward D Agura; Thomas R Chauncey; David G Maloney; Judith A Shizuru; Rainer Storb
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):272-9.
2005: Frédéric Baron; Michael B Maris; Brenda M Sandmaier; Barry E Storer; Mohamed L Sorror; Razvan Diaconescu; Ann Woolfrey; Thomas R Chauncey; Mary E D Flowers; Marco Mielcarek; David G Maloney; Rainer Storb
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1993-2003.
2005: Marco Mielcarek; Ted Gooley; Paul J Martin; Thomas R Chauncey; Bessie A Young; Rainer Storb; Beverly Torok-Storb
Effects of race on survival after stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(3):231-9.
2005: Jens P Panse; Shelly Heimfeld; Katherine A Guthrie; Michael B Maris; David G Maloney; B B Baril; Marie-Térèse Little; Thomas R Chauncey; Barry E Storer; Rainer Storb; Brenda M Sandmaier
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning.
British journal of haematology 2005;128(5):659-67.
2005: Vivian G Oehler; Jerald P Radich; Barry Storer; Karl G Blume; Thomas R Chauncey; Reginald Clift; David S Snyder; Stephen J Forman; Mary E D Flowers; Paul Martin; Katherine A Guthrie; Robert S Negrin; Frederick R Appelbaum; William I Bensinger
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):85-92.
2004: Bart Scott; H Joachim Deeg; Barry Storer; Thomas R Chauncey; Stephen H Petersdorf; John Slattery; Frederick R Appelbaum
Targeted busulfan and cyclophosphamide as compared to busulfan and TBI as preparative regimens for transplantation in patients with advanced MDS or transformation to AML.
Leukemia & lymphoma 2004;45(12):2409-17.
2004: Michael B Maris; Brenda M Sandmaier; Barry E Storer; Thomas R Chauncey; Monic J Stuart; Richard T Maziarz; Edward Agura; Amelia A Langston; Michael Allen Pulsipher; Rainer Storb; David G Maloney
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.
Blood 2004;104(12):3535-42.
2004: Frédéric Baron; Jennifer E Baker; Rainer Storb; Theodore A Gooley; Brenda M Sandmaier; Michael B Maris; David G Maloney; Shelly Heimfeld; Dmitrij Oparin; Eustacia Zellmer; Jerald P Radich; F Carl Grumet; Karl G Blume; Thomas R Chauncey; Marie-Térèse Little
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2004;104(8):2254-62.
2004: Thomas R Chauncey
Autologous bone marrow transplantation improves disease free survival but not overall survival in people with acute myeloid leukaemia.
Cancer treatment reviews 2004;30(5):483-7.
2004: Wolfgang A Bethge; Ute Hegenbart; Monic J Stuart; Barry E Storer; Michael B Maris; Mary E D Flowers; David G Maloney; Thomas R Chauncey; Benedetto Bruno; Edward Agura; Stephen J Forman; Karl G Blume; Dietger Niederwieser; Rainer Storb; Brenda M Sandmaier
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.
Blood 2004;103(3):790-5.
2003: H Joachim Deeg; Theodore A Gooley; Mary E D Flowers; George E Sale; John T Slattery; Claudio Anasetti; Thomas R Chauncey; Kristine C Doney; George E Georges; Hans-Peter Kiem; Paul J Martin; Effie W Petersdorf; Jerald P Radich; Jean E Sanders; Brenda M Sandmaier; Edus H Warren; Robert P Witherspoon; Rainer Storb; Frederick R Appelbaum
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Blood 2003;102(12):3912-8.
2003: David G Maloney; Arthur J Molina; Firoozeh Sahebi; Keith E Stockerl-Goldstein; Brenda M Sandmaier; William I Bensinger; Barry Storer; Ute Hegenbart; George Somlo; Thomas R Chauncey; Benedetto Bruno; Frederick R Appelbaum; Karl G Blume; Stephen J Forman; Peter McSweeney; Rainer Storb
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.
Blood 2003;102(9):3447-54.
2003: Wolfgang A Bethge; Barry E Storer; Michael B Maris; Mary E D Flowers; David G Maloney; Thomas R Chauncey; Ann Woolfrey; Rainer Storb; Brenda M Sandmaier
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome.
Experimental hematology 2003;31(10):974-80.
2003: Michael B Maris; Dietger Niederwieser; Brenda M Sandmaier; Barry Storer; Monic Stuart; David Maloney; Effie W Petersdorf; Peter McSweeney; Michael Allen Pulsipher; Ann Woolfrey; Thomas R Chauncey; Edward Agura; Shelly Heimfeld; John Slattery; Ute Hegenbart; Claudio Anasetti; Karl G Blume; Rainer Storb
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.
Blood 2003;102(6):2021-30.
2003: F Gutierrez-Delgado; Leona A Holmberg; Heather A Hooper; Stephen H Petersdorf; Oliver W Press; Richard T Maziarz; David Maloney; Thomas R Chauncey; Frederick R Appelbaum; William I Bensinger
Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen.
Bone marrow transplantation 2003;32(3):279-85.
2003: Kristine C Doney; Hans Hägglund; Wendy Leisenring; Thomas R Chauncey; Frederick R Appelbaum; Rainer Storb
Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(7):472-81.
2003: Jerald P Radich; Ted Gooley; William I Bensinger; Thomas R Chauncey; Reginald Clift; Mary Flowers; Paul Martin; John Slattery; Debbie Sultan; Frederick R Appelbaum
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen.
Blood 2003;102(1):31-5.
2003: Lyle Feinstein; Brenda M Sandmaier; David G Maloney; Michael B Maris; Theodore A Gooley; Thomas R Chauncey; Ute Hegenbart; Peter A McSweeney; Monic J Stuart; Stephen J Forman; Edward Agura; Michael Allen Pulsipher; Karl G Blume; Dietger Niederwieser; Rainer F Storb
Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(4):266-72.
2003: Dietger Niederwieser; Michael B Maris; Judith A Shizuru; Effie W Petersdorf; Ute Hegenbart; Brenda M Sandmaier; David G Maloney; Barry Storer; Thoralf Lange; Thomas R Chauncey; Michael W N Deininger; Wolfram Pönisch; Claudio Anasetti; Ann Woolfrey; Marie-Térèse Little; Karl G Blume; Peter A McSweeney; Rainer F Storb
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.
Blood 2003;101(4):1620-9.
2003: Lyle Feinstein; Brenda M Sandmaier; Ute Hegenbart; Peter A McSweeney; David G Maloney; Theodore A Gooley; Michael B Maris; Thomas R Chauncey; Benedetto Bruno; Frederick R Appelbaum; Dietger Niederwieser; Rainer F Storb
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
British journal of haematology 2003;120(2):281-8.
2002: J Maciej Zaucha; Marco Mielcarek; Alessandra Takatu; Marie-Térèse Little; Ted Gooley; Jennifer Baker; David G Maloney; Brenda M Sandmaier; Michael B Maris; Thomas R Chauncey; Rainer Storb; Beverly Torok-Storb
Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.
British journal of haematology 2002;119(3):740-50.
2002: Kai Hübel; Rachel A Carter; W Conrad Liles; David C Dale; Thomas H Price; Raleigh A Bowden; Scott D Rowley; Thomas R Chauncey; William I Bensinger; Michael Boeckh
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.
Transfusion 2002;42(11):1414-21.
2002: H Joachim Deeg; Barry Storer; John T Slattery; Claudio Anasetti; Kristine C Doney; John A Hansen; Hans-Peter Kiem; Paul J Martin; Effie W Petersdorf; Jerald P Radich; Jean E Sanders; Howard M Shulman; Edus H Warren; Robert P Witherspoon; Eileen Bryant; Thomas R Chauncey; Lisa Getzendaner; Rainer Storb; Frederick R Appelbaum
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
Blood 2002;100(4):1201-7.
2002: George E Georges; Michael B Maris; Brenda M Sandmaier; David G Malone; Lyle Feinstein; Dietger Niederweiser; Judith A Shizuru; Peter A McSweeney; Thomas R Chauncey; Edward Agura; Marie-Térèse Little; Firoozeh Sahebi; Ute Hegenbart; Michael Allen Pulsipher; Benedetto Bruno; Stephen Forman; Ann Woolfrey; Jerald P Radich; Karl G Blume; Rainer Storb
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
International journal of hematology 2002;76 Suppl 1():184-9.
2002: Uwe Platzbecker; Ted Gooley; Claudio Anasetti; Frederick R Appelbaum; Bruce E Clurman; Kristine C Doney; Thomas R Chauncey; Mary E D Flowers; David Myerson; Jerald P Radich; Rainer Storb; Robert P Witherspoon; H Joachim Deeg
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation.
Leukemia & lymphoma 2002;43(7):1409-14.
2002: Kristine C Doney; Thomas R Chauncey; Frederick R Appelbaum
Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.
Bone marrow transplantation 2002;29(10):817-23.
2002: Christian Junghanss; Michael Boeckh; Rachel A Carter; Brenda M Sandmaier; Michael B Maris; David G Maloney; Thomas R Chauncey; Peter A McSweeney; Marie-Térèse Little; Lawrence Corey; Rainer Storb
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.
Blood 2002;99(6):1978-85.
2002: Marco Mielcarek; Brenda M Sandmaier; David G Maloney; Michael B Maris; Peter A McSweeney; Ann Woolfrey; Thomas R Chauncey; Lyle Feinstein; Dietger Niederwieser; Karl G Blume; Stephen Forman; Beverly Torok-Storb; Rainer Storb
Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.
Journal of clinical immunology 2002;22(2):70-4.
2002: Christian Junghanss; Kieren Marr; Rachel A Carter; Brenda M Sandmaier; Michael B Maris; David G Maloney; Thomas R Chauncey; Peter A McSweeney; Rainer Storb
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):512-20.
2002: Fulvio Crippa; Leona A Holmberg; Rachel A Carter; Heather A Hooper; Kieren Marr; William I Bensinger; Thomas R Chauncey; Lawrence Corey; Michael Boeckh
Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(5):281-9.
2002: Manuel Jurado; H Joachim Deeg; Barry Storer; Claudio Anasetti; Jeanne E Anderson; Eileen Bryant; Thomas R Chauncey; Kristine C Doney; Mary E D Flowers; John Hansen; Paul J Martin; Richard A Nash; Effie W Petersdorf; Jerald P Radich; George E Sale; Brenda M Sandmaier; Rainer Storb; James Wade; Robert P Witherspoon; Frederick R Appelhaum
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):161-9.
2001: Jan M Zaucha; Ted Gooley; William I Bensinger; Shelly Heimfeld; Thomas R Chauncey; R Zaucha; P J Martin; Mary E D Flowers; Jan Storek; George E Georges; Rainer Storb; Beverly Torok-Storb
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation.
Blood 2001;98(12):3221-7.
2001: Jerald P Radich; Ted Gooley; Eileen Bryant; Thomas R Chauncey; Reginald Clift; Lan Beppu; S Edmands; Mary E D Flowers; K Kerkof; R Nelson; Frederick R Appelbaum
The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation.
Blood 2001;98(6):1701-7.
2001: Michael B Maris; Ann Woolfrey; Peter A McSweeney; Brenda M Sandmaier; Richard A Nash; George E Georges; David G Maloney; A Molina; Thomas R Chauncey; Cong Yu; Jan M Zaucha; Karl G Blume; Judith A Shizuru; Dietger Niederwieser; Rainer Storb
Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century.
Frontiers in bioscience : a journal and virtual library 2001;6():G13-6.
2001: Jeanne E Anderson; Ayalew Tefferi; F Craig; L Holmberg; Thomas R Chauncey; Frederick R Appelbaum; Philippe Guardiola; Natalie S Callander; Cesar O Freytes; Yair Gazitt; B Razvillas; H J Deeg
Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis.
Blood 2001;98(3):586-93.
2001: Michael B Maris; Brenda M Sandmaier; David G Maloney; Peter A McSweeney; Ann Woolfrey; Thomas R Chauncey; Judith A Shizuru; Dietger Niederwieser; Karl G Blume; Stephen Forman; Rainer Storb
Non-myeloablative hematopoietic stem cell transplantation.
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(3):231-4.
2001: Lyle Feinstein; Brenda M Sandmaier; David Maloney; Peter A McSweeney; Michael B Maris; Christopher R Flowers; Jerald P Radich; Marie-Térèse Little; Richard A Nash; Thomas R Chauncey; Ann Woolfrey; George E Georges; Hans-Peter Kiem; Jan M Zaucha; Karl G Blume; Judith A Shizuru; Dietger Niederwieser; Rainer Storb
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Annals of the New York Academy of Sciences 2001;938():328-37; discussion 337-9.
2001: Peter A McSweeney; Dietger Niederwieser; Judith A Shizuru; Brenda M Sandmaier; A J Molina; David G Maloney; Thomas R Chauncey; Theodore A Gooley; Ute Hegenbart; Richard A Nash; Jerald P Radich; JL Wagner; S Minor; Frederick R Appelbaum; William I Bensinger; Eileen Bryant; Mary E D Flowers; George E Georges; F Carl Grumet; Hans-Peter Kiem; Beverly Torok-Storb; Cong Yu; Karl G Blume; Rainer Storb
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Blood 2001;97(11):3390-400.
2001: M Jurado; H Joachim Deeg; Ted Gooley; Claudio Anasetti; Thomas R Chauncey; Mary Flowers; David Myerson; Rainer Storb; Frederick R Appelbaum
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia.
British journal of haematology 2001;112(2):392-6.
2001: William I Bensinger; Paul J Martin; Barry Storer; Reginald Clift; Stephen J Forman; Robert S Negrin; A Kashyap; Mary E D Flowers; Kathy Lilleby; Thomas R Chauncey; Rainer Storb; Frederick R Appelbaum
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
The New England journal of medicine 2001;344(3):175-81.
2001: Jeanne E Anderson; Frederick R Appelbaum; Gary Schoch; T Barnett; Thomas R Chauncey; M E Flowers; Rainer Storb
Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(3):163-70.
2001: Rainer Storb; Karl G Blume; Margaret R O'Donnell; Thomas R Chauncey; Stephen J Forman; H Joachim Deeg; Wendy W Hu; Frederick R Appelbaum; Kristine C Doney; Mary E D Flowers; Jean Sanders; Wendy Leisenring
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):39-44.
2000: Rainer Storb; Peter A McSweeney; Brenda M Sandmaier; Richard A Nash; George E Georges; David G Maloney; A Molina; Thomas R Chauncey; Cong Yu; Jan M Zaucha; Karl G Blume; Judith A Shizuru; Dietger Niederwieser
Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the twenty-first century.
Transplantation proceedings 2000;32(7):2548-9.
2000: Thomas R Chauncey; Theodore A Gooley; Michele E Lloid; Mark M Schubert; Kathy Lilleby; Leona A Holmberg; William I Bensinger
Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
American journal of clinical oncology 2000;23(4):406-11.
2000: Mary E D Flowers; Wendy Leisenring; K Beach; Stanley R Riddell; Jerald P Radich; C S Higano; Scott D Rowley; Thomas R Chauncey; Jean E Sanders; Claudio Anasetti; Rainer Storb; J Wade; Frederick R Appelbaum; Paul Martin
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3A):321-6.
1999: Paul J Martin; Scott D Rowley; Claudio Anasetti; Thomas R Chauncey; Ted Gooley; Effie W Petersdorf; Jo-Anne H van Burik; Mary E D Flowers; Rainer Storb; Frederick R Appelbaum; John A Hansen
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.
Blood 1999;94(7):2192-9.
1998: John A Hansen; Theodore A Gooley; Paul J Martin; Frederick R Appelbaum; Thomas R Chauncey; Reginald Clift; Effie W Petersdorf; Jerald P Radich; Jean E Sanders; Rainer Storb; Keith M Sullivan; Claudio Anasetti
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.
The New England journal of medicine 1998;338(14):962-8.
1998: Michael Boeckh; John A Zaia; D Jung; S Skettino; Thomas R Chauncey; Raleigh A Bowden
A study of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for CMV prophylaxis in marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(1):13-9.
1997: Jan Storek; Ted Gooley; MF Siadak; William I Bensinger; D G Maloney; Thomas R Chauncey; Mary Flowers; Keith M Sullivan; Robert P Witherspoon; S D Rowley; John A Hansen; Rainer Storb; Frederick R Appelbaum
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease.
Blood 1997;90(12):4705-9.
1997: K Schiffman; C Dean Buckner; Richard T Maziarz; David G Maloney; Frederick R Appelbaum; Oliver W Press; Ted Gooley; Leona A Holmberg; Kathy Lilleby; Reginald Clift; N Zuckerman; JP Klarnet; C Weaver; Thomas R Chauncey; William I Bensinger
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):261-6.
1997: Rainer Storb; Wendy Leisenring; Claudio Anasetti; Frederick R Appelbaum; H Joachim Deeg; Kristine C Doney; Paul Martin; Keith M Sullivan; Robert P Witherspoon; Mary Pettinger; William I Bensinger; C Dean Buckner; Reginald Clift; Mary E D Flowers; John A Hansen; M Pepe; Thomas R Chauncey; Jean Sanders; ED Thomas
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):194-201.
1997: J E Anderson; George E Sale; F R Appelbaum; Thomas R Chauncey; R Storb
Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis.
British journal of haematology 1997;98(4):1010-6.
1997: Jorge Sierra; Barry Storer; John A Hansen; JW Bjerke; Paul J Martin; Effie W Petersdorf; Frederick R Appelbaum; Eileen Bryant; Thomas R Chauncey; George E Sale; Jean E Sanders; Rainer Storb; Keith M Sullivan; Claudio Anasetti
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.
Blood 1997;89(11):4226-35.
1997: Jan Storek; Robert P Witherspoon; D G Maloney; Thomas R Chauncey; R Storb
Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow.
Blood 1997;89(10):3891-3.
1997: R Storb; Wendy Leisenring; Claudio Anasetti; F R Appelbaum; C Dean Buckner; William I Bensinger; Thomas R Chauncey; Reginald Clift; H Joachim Deeg; Kristine C Doney; Mary E D Flowers; John A Hansen; Paul J Martin; Jean E Sanders; Keith M Sullivan; Robert P Witherspoon
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.
Blood 1997;89(10):3890-1.
1997: H Joachim Deeg; D Lin; Wendy Leisenring; Michael Boeckh; Claudio Anasetti; Frederick R Appelbaum; Thomas R Chauncey; Kristine C Doney; Mary Flowers; Paul Martin; Richard Nash; Gary Schoch; Keith M Sullivan; Robert P Witherspoon; Rainer Storb
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Blood 1997;89(10):3880-7.
1997: John T Slattery; Reginald Clift; C Dean Buckner; Jerald P Radich; Barry Storer; William I Bensinger; E Soll; Claudio Anasetti; Raleigh Bowden; Eileen Bryant; Thomas R Chauncey; H Joachim Deeg; Kristine C Doney; Mary Flowers; Ted Gooley; John A Hansen; Paul J Martin; George B McDonald; Richard Nash; Effie W Petersdorf; Jean E Sanders; Gary Schoch; P Stewart; Rainer Storb; Keith M Sullivan; ED Thomas; Robert P Witherspoon; Frederick R Appelbaum
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Blood 1997;89(8):3055-60.
1997: N Robinson; M C Benyunes; JA Thompson; A York; Stephen H Petersdorf; Oliver W Press; CG Lindgren; Thomas R Chauncey; C Dean Buckner; William I Bensinger; Frederick R Appelbaum; Alexander Fefer
Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study.
Bone marrow transplantation 1997;19(5):435-42.
1996: William I Bensinger; C Dean Buckner; Claudio Anasetti; Reginald Clift; Rainer Storb; T Barnett; Thomas R Chauncey; Howard M Shulman; Frederick R Appelbaum
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome.
Blood 1996;88(7):2787-93.
1996: M W Brunvand; William I Bensinger; E Soll; Charles H Weaver; Scott D Rowley; Frederick R Appelbaum; Kathy Lilleby; Reginald Clift; T A Gooley; Oliver W Press; Alexander Fefer; Rainer Storb; Jean E Sanders; P L Martin; Thomas R Chauncey; Richard T Maziarz; N Zuckerman; P Montgomery; R Dorn; P L Weiden; Taner Demirer; Leona A Holmberg; K Schiffman; P A McSweeney; C Dean Buckner
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1996;18(1):131-41.
1996: Taner Demirer; F B Petersen; William I Bensinger; F R Appelbaum; Alexander Fefer; Scott D Rowley; Jean Sanders; Thomas R Chauncey; R Storb; Kathy Lilleby; C D Buckner
Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
Bone marrow transplantation 1996;18(1):29-34.
1996: Taner Demirer; C Dean Buckner; T Gooley; Frederick R Appelbaum; Scott D Rowley; Thomas R Chauncey; Kathy Lilleby; Rainer Storb; William I Bensinger
Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
Bone marrow transplantation 1996;17(6):937-41.
1996: William I Bensinger; Scott D Rowley; Taner Demirer; Kathy Lilleby; K Schiffman; Reginald Clift; Frederick R Appelbaum; Alexander Fefer; T Barnett; Rainer Storb; Thomas R Chauncey; Richard T Maziarz; J Klarnet; P McSweeney; Leona A Holmberg; David G Maloney; Charles H Weaver; C Dean Buckner
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1447-56.
1996: J E Anderson; Frederick R Appelbaum; Gary Schoch; T Gooley; Claudio Anasetti; William I Bensinger; Eileen Bryant; C Dean Buckner; Thomas R Chauncey; Reginald Clift
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):220-6.
1996: J E Anderson; Frederick R Appelbaum; Gary Schoch; T Gooley; Claudio Anasetti; William I Bensinger; Eileen Bryant; C Dean Buckner; Thomas R Chauncey; Reginald Clift; Kristine C Doney; M Flowers; John A Hansen; Paul J Martin; Dana C Matthews; Jean E Sanders; Howard M Shulman; K M Sullivan; Robert P Witherspoon; Rainer Storb
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Blood 1996;87(1):51-8.
1995: Taner Demirer; C Dean Buckner; Frederick R Appelbaum; F B Petersen; Scott D Rowley; Charles H Weaver; Kathy Lilleby; Jean Sanders; Thomas R Chauncey; Rainer Storb
Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
Bone marrow transplantation 1995;15(6):915-22.